iSpecimen Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
iSpecimen Inc. (ISPC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $3.04 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-01
- iSpecimen Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $3.04M, a 19.20% decline from fiscal 2023.
- iSpecimen Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $3.77M, a 37.38% increase from fiscal 2022.
- iSpecimen Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.74M, a 204.78% increase from fiscal 2021.
- iSpecimen Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $900.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2024-12-31 | $3.04M 10-K · filed 2026-04-01 |
| 2023-12-31 | $3.77M 10-K · filed 2024-03-13 |
| 2022-12-31 | $2.74M 10-K/A · filed 2023-03-30 |
| 2021-12-31 | $900.00K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |